Free Trial

NeuroBo Pharmaceuticals (NRBO) Competitors

NeuroBo Pharmaceuticals logo
$0.72 0.00 (0.00%)
As of 07/11/2025

NRBO vs. ARBK, JFU, GLBZ, ANY, NCPL, SAIH, LMFA, MCVT, SLNH, and MIGI

Should you be buying NeuroBo Pharmaceuticals stock or one of its competitors? The main competitors of NeuroBo Pharmaceuticals include Argo Blockchain (ARBK), 9F (JFU), Glen Burnie Bancorp (GLBZ), Sphere 3D (ANY), Netcapital (NCPL), SAIHEAT (SAIH), LM Funding America (LMFA), Mill City Ventures III (MCVT), Soluna (SLNH), and Mawson Infrastructure Group (MIGI). These companies are all part of the "banking" industry.

NeuroBo Pharmaceuticals vs. Its Competitors

Argo Blockchain (NASDAQ:ARBK) and NeuroBo Pharmaceuticals (NASDAQ:NRBO) are both small-cap banking companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

2.4% of Argo Blockchain shares are held by institutional investors. Comparatively, 1.4% of NeuroBo Pharmaceuticals shares are held by institutional investors. 1.1% of NeuroBo Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Argo Blockchain had 3 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 3 mentions for Argo Blockchain and 0 mentions for NeuroBo Pharmaceuticals. Argo Blockchain's average media sentiment score of 0.88 beat NeuroBo Pharmaceuticals' score of 0.00 indicating that Argo Blockchain is being referred to more favorably in the media.

Company Overall Sentiment
Argo Blockchain Positive
NeuroBo Pharmaceuticals Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Argo Blockchain
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
NeuroBo Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

NeuroBo Pharmaceuticals has a net margin of 0.00% compared to Argo Blockchain's net margin of -117.38%. Argo Blockchain's return on equity of 0.00% beat NeuroBo Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Argo Blockchain-117.38% N/A -79.90%
NeuroBo Pharmaceuticals N/A -189.12%-122.31%

NeuroBo Pharmaceuticals has lower revenue, but higher earnings than Argo Blockchain.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Argo Blockchain$47.02M0.46-$55.10M-$0.97-0.31
NeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/A

Argo Blockchain has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500. Comparatively, NeuroBo Pharmaceuticals has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500.

Summary

Argo Blockchain beats NeuroBo Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

Get NeuroBo Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRBO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRBO vs. The Competition

MetricNeuroBo PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$6.19M$872.67M$5.62B$9.09B
Dividend YieldN/A4.84%5.24%4.00%
P/E RatioN/A1.3828.1320.27
Price / SalesN/A239.36428.2698.57
Price / CashN/A17.6937.4658.16
Price / Book0.486.588.045.49
Net Income-$12.47M-$23.83M$3.18B$250.45M
7 Day Performance10.82%1.59%3.62%4.79%
1 Month Performance-7.35%12.08%4.06%7.68%
1 Year Performance-85.64%4.39%30.01%16.43%

NeuroBo Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRBO
NeuroBo Pharmaceuticals
N/A$0.72
flat
N/A-85.2%$6.19MN/A0.0010Gap Down
ARBK
Argo Blockchain
0.9646 of 5 stars
$0.29
+11.7%
N/A-72.7%$21.22M$48.52M-0.3040News Coverage
Gap Up
High Trading Volume
JFU
9F
1.8425 of 5 stars
$1.67
+15.6%
N/A-22.7%$19.56M$58.09M0.00740News Coverage
Positive News
GLBZ
Glen Burnie Bancorp
1.8835 of 5 stars
$5.67
-0.6%
N/A+37.9%$16.46M$16.37M568.0780Positive News
ANY
Sphere 3D
3.0646 of 5 stars
$0.60
+1.5%
$3.00
+396.7%
-31.4%$15.96M$16.61M-1.0620Positive News
Gap Up
NCPL
Netcapital
0.3326 of 5 stars
$6.56
-6.3%
N/A+4.9%$14.41M$4.95M-0.33N/AGap Up
SAIH
SAIHEAT
N/A$8.05
+2.3%
N/AN/A$14.09M$5.54M0.0037Gap Up
LMFA
LM Funding America
1.3419 of 5 stars
$2.43
+3.4%
N/A-40.9%$12.45M$11M-0.368News Coverage
Analyst Downgrade
Gap Up
MCVT
Mill City Ventures III
3.1671 of 5 stars
$1.85
-2.1%
N/A-33.9%$11.22M$3.30M9.742
SLNH
Soluna
1.8663 of 5 stars
$0.81
+18.7%
N/A-71.5%$11.12M$31.41M-0.0760High Trading Volume
MIGI
Mawson Infrastructure Group
1.2825 of 5 stars
$0.50
flat
N/A-57.0%$9.80M$59.26M-0.3440Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:NRBO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners